調查批次:CHT2015-10 | 檢體寄出日期:2015-10-26 | 報告回收截止日期:2015-11-02 | 回收份數:21 |
TSH 檢驗院際品管調查結果: | ||
2.歷次品管檢體 TSH 檢驗值之實驗室間 CV 分佈圖 | ||
4.至本次各單位 z score 分佈圖 | 5.至本次各單位 D% 分佈圖 | 6.至本次各單位 SDI 分佈圖 |
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( mIU/L ) |
D |
D% |
z |
SDI |
Da% |
( mIU/L ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01b | RH01 | 2 |
1 |
3 |
32.0 |
11.5 |
56.1 |
7.0 |
1.6 |
234 |
8.5 |
2.6 |
44.1 |
5.5 |
0.7 |
184 |
RH07b | RH07 | 7 |
1 |
3 |
29.0 |
8.5 |
41.5 |
5.2 |
-0.2 |
173 |
8.0 |
2.1 |
35.6 |
4.5 |
0.0 |
149 |
RH14 | RH14 | 4 |
1 |
3 |
28.1 |
7.6 |
37.1 |
4.6 |
-0.8 |
154 |
7.8 |
1.9 |
32.2 |
4.0 |
-0.3 |
135 |
RH15 | RH15 | 7 |
1 |
3 |
29.4 |
8.9 |
43.4 |
5.4 |
0.0 |
181 |
7.8 |
1.9 |
32.2 |
4.0 |
-0.3 |
135 |
CL009 | CL009 | 4 |
1 |
3 |
29.1 |
8.6 |
42.0 |
5.2 |
-0.2 |
175 |
7.9 |
2.0 |
33.9 |
4.3 |
-0.1 |
142 |
CL010 | CL010 | 3 |
1 |
3 |
29.9 |
9.4 |
45.9 |
5.7 |
0.3 |
191 |
7.7 |
1.8 |
30.5 |
3.8 |
-0.4 |
128 |
CL012 | CL012 | 7 |
1 |
3 |
28.0 |
7.5 |
36.6 |
4.6 |
-0.9 |
152 |
9.0 |
3.1 |
52.5 |
6.6 |
1.4 |
220 |
CL013 | CL013 | 3 |
1 |
5 |
28.5 |
8.0 |
39.0 |
4.9 |
-0.6 |
163 |
7.0 |
1.1 |
18.6 |
2.3 |
-1.4 |
78 |
CL014a | CL014 | 4 |
1 |
3 |
28.0 |
7.5 |
36.6 |
4.6 |
-0.9 |
152 |
7.6 |
1.7 |
28.8 |
3.6 |
-0.5 |
121 |
CL015 | CL015 | 4 |
1 |
3 |
32.5 |
12.0 |
58.5 |
7.3 |
1.9 |
244 |
9.1 |
3.2 |
54.2 |
6.8 |
1.5 |
227 |
Median of RIA Group |
29.1 |
7.9 |
||||||||||||||
Range of RIA Group |
28.0 - 32.5 |
7.0 - 9.1 |
||||||||||||||
Robust mean of RIA Group |
29.4 ( n = 10 ) |
8.0 ( n = 10 ) |
||||||||||||||
Robust SD of RIA Group |
1.61 |
0.74 |
||||||||||||||
CV of RIA Group |
5.5% |
9.3% |
||||||||||||||
Median of European RIA Labs |
21.4 ( n = 106 ) |
6.1 ( n = 106 ) |
||||||||||||||
Range of European RIA Labs ( 16% - 84% ) |
19.8 - 27.8 |
5.5 - 8.0 |
||||||||||||||
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( mIU/L ) |
D |
D% |
z |
SDI |
Da% |
( mIU/L ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01a | RH01 | 3 |
3 |
9 |
16.6 |
-3.9 |
-19.0 |
-2.4 |
-1.1 |
-79 |
5.7 |
-0.2 |
-3.4 |
-0.4 |
0.4 |
-14 |
RH02c | RH02 | 1 |
3 |
1 |
16.9 |
-3.6 |
-17.6 |
-2.2 |
-1.0 |
-73 |
5.2 |
-0.7 |
-11.9 |
-1.5 |
-0.7 |
-50 |
RH06 | RH06 | 2 |
3 |
9 |
21.4 |
0.9 |
4.4 |
0.5 |
1.1 |
18 |
5.2 |
-0.7 |
-11.9 |
-1.5 |
-0.7 |
-50 |
RH07a | RH07 | 1 |
3 |
2 |
17.3 |
-3.2 |
-15.6 |
-2.0 |
-0.8 |
-65 |
5.0 |
-0.9 |
-15.3 |
-1.9 |
-1.1 |
-64 |
RH12 | RH12 | 7 |
3 |
2 |
21.6 |
1.1 |
5.4 |
0.7 |
1.2 |
22 |
6.1 |
0.2 |
3.4 |
0.4 |
1.3 |
14 |
RH19 | RH19 | 2 |
3 |
2 |
20.9 |
0.4 |
2.0 |
0.2 |
0.9 |
8 |
6.1 |
0.2 |
3.4 |
0.4 |
1.3 |
14 |
RH20 | RH20 | 3 |
3 |
7 |
18.2 |
-2.3 |
-11.2 |
-1.4 |
-0.4 |
-47 |
5.3 |
-0.6 |
-10.2 |
-1.3 |
-0.4 |
-43 |
CL005 | CL005 | 7 |
3 |
9 |
18.1 |
-2.4 |
-11.7 |
-1.5 |
-0.4 |
-49 |
5.4 |
-0.5 |
-8.5 |
-1.1 |
-0.2 |
-35 |
CL006a | CL006 | 3 |
3 |
7 |
18.4 |
-2.1 |
-10.2 |
-1.3 |
-0.3 |
-43 |
5.3 |
-0.6 |
-10.2 |
-1.3 |
-0.4 |
-43 |
CL008 | CL008 | 4 |
3 |
2 |
18.6 |
-1.9 |
-9.3 |
-1.2 |
-0.2 |
-39 |
5.3 |
-0.6 |
-10.2 |
-1.3 |
-0.4 |
-43 |
CL011 | CL011 | 1 |
3 |
13 |
20.8 |
0.3 |
1.5 |
0.2 |
0.9 |
6 |
6.1 |
0.2 |
3.4 |
0.4 |
1.3 |
14 |
Median of CLIA Group |
18.4 |
5.3 |
||||||||||||||
Range of CLIA Group |
16.6 - 21.6 |
5.0 - 6.1 |
||||||||||||||
Robust mean of CLIA Group |
19.0 ( n = 11 ) |
5.5 ( n = 11 ) |
||||||||||||||
Robust SD of CLIA Group |
2.10 |
0.46 |
||||||||||||||
CV of CLIA Group |
11.1% |
8.4% |
||||||||||||||
Median of European CLIA Labs |
20.5 ( n = 1212 ) |
5.9 ( n = 1212 ) |
||||||||||||||
Range of European CLIA Labs ( 16% - 84% ) |
17.1 - 21.7 |
5.1 - 6.3 |
||||||||||||||
Median of All Labs |
21.6 |
6.1 |
||||||||||||||
Range of All Labs |
16.6 - 32.5 |
5.0 - 9.1 |
||||||||||||||
Robust mean of All Labs |
24.0 ( n = 21 ) |
6.7 ( n = 21 ) |
||||||||||||||
Robust SD of All Labs |
6.37 |
1.58 |
||||||||||||||
CV of All Labs |
26.5% |
23.6%
|
||||||||||||||
Median of All European Labs ( Xa ) |
20.5 |
5.9 |
||||||||||||||
Range of All European Labs ( 16% - 84% ) |
17.2 - 22.0 |
5.1 - 6.3 |
||||||||||||||
Mean of All European Labs |
20.2 ( n = 1426 ) |
5.9 ( n = 1426 ) |
||||||||||||||
SD of All European Labs |
2.73 |
0.75 |
||||||||||||||
CV of All European Labs |
13.5% |
12.7% |
||||||||||||||
SD for proficiency
assessment ( σp ) |
1.642 |
0.472 |
||||||||||||||
|
Method Code
|
Laboratory |
|
Radioimmunoassay ( Sandwich-type ) |
1 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL013, CL014a, CL015, |
Chemiluminescent Immunoassay ( Sandwich-type ) |
3 |
RH01a, RH02c, RH06, RH07a, RH12, RH19, RH20, CL005, CL006a, CL008, CL011, |
Reagent Code |
Laboratory |
|
Abbott Architect |
1 |
RH02c, |
Beckman Coulter Access |
2 |
RH07a, RH12, RH19, CL008, |
Cisbio RIA-gnost |
3 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL014a, CL015, |
Immunotech |
5 |
CL013, |
Siemens ADVIA Centaur |
7 |
RH20, CL006a, |
Siemens Immulite 2000 |
9 |
RH01a, RH06, CL005, |
Roche |
13 |
CL011, |
若有任何疑問,歡迎來電(函)聯繫或指教
財團法人預防醫學基金會
地 址:10699 台北郵政 26-624 號信箱 電 話:(02)
2703-6080
e-mail:
傳 真: (02)
2703-6070
updated
: 2015-11-03